journal article·2024-11-05Open access

Development of Nanocomposite Microspheres for Nasal Administration of Deferiprone in Neurodegenerative Disorders

Radka Boyuklieva, Plamen Katsarov, Plamen Zagorchev, Silviya Abarova, Asya Hristozova, Bissera Pilicheva

Journal of Functional Biomaterials· Volume 15· Issue 11

Abstract

Elevated brain iron levels are characteristic of many neurodegenerative diseases. As an iron chelator with short biological half-life, deferiprone leads to agranulocytosis and neutropenia with a prolonged therapeutic course. Its inclusion in sustained-release dosage forms may reduce the frequency of administration. On the other hand, when administered by an alternative route of administration, such as the nasal route, systemic exposure to deferiprone will be reduced, thereby reducing the occurrence of adverse effects. Direct nose-to-brain delivery has been raised as a non-invasive strategy to deliver drugs to the brain, bypassing the blood–brain barrier. The aim of the study was to develop and characterize nanocomposite microspheres suitable for intranasal administration by combining nano- and microparticle-based approaches. Nanoparticles with an average particle size of 213 ± 56 nm based on the biodegradable polymer poly-ε-caprolactone were developed using the solvent evaporation method. To ensure the deposition of the particles in the nasal cavity and avoid exhalation or deposition into the small airways, the nanoparticles were incorporated into composite structures of sodium alginate obtained by spray drying. Deferiprone demonstrated sustained release from the nanocomposite microspheres and high iron-chelating activity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Pharmaceutical studies and practices · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria

Research Institute, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria

Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria

Department of Medical Physics and Biophysics, Faculty of Medicine, Medical University of Sofia, 1000 Sofia, Bulgaria

Department of Analytical Chemistry and Computational Chemistry, Faculty of Chemistry, University of Plovdiv “Paisii Hilendarski”, 4000 Plovdiv, Bulgaria

Funding

European Union—NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria

References (72)

Show source-provided references
1. De la Torre, C., and Ceña, V. (2018). The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer’s Disease Therapeutics and Diagnostics. Pharmaceutics, 10.10.3390/pharmaceutics10040190 ↗
2. Domínguez-Fernández, C., Egiguren-Ortiz, J., Razquin, J., Gómez-Galán, M., De las Heras-García, L., Paredes-Rodríguez, E., Astigarraga, E., Miguélez, C., and Barreda-Gómez, G. (2023). Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders. Int. J. Mol. Sci., 24.10.3390/ijms24043321 ↗
3. Aragón-González, A., Shaw, P.J., and Ferraiuolo, L. (2022). Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders. Int. J. Mol. Sci., 23.10.3390/ijms232315271 ↗
4. Xu, H., Wang, Y., Song, N., Wang, J., Jiang, H., and Xie, J. (2017). New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson’s Disease. Front. Mol. Neurosci., 10.10.3389/fnmol.2017.00455 ↗
5. Neurodegenerative diseases and therapeutic strategies using iron chelators10.1016/j.jtemb.2014.12.012 ↗
6. Long, H.Z., Zhou, Z.W., Cheng, Y., Luo, H.Y., Li, F.J., Xu, S.G., and Gao, L.C. (2022). The Role of Microglia in Alzheimer’s Disease from the Perspective of Immune Inflammation and Iron Metabolism. Front. Aging Neurosci., 14.10.3389/fnagi.2022.888989 ↗
7. Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients10.1186/s40478-021-01126-5 ↗
8. Wang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., and Li, G. (2023). Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer’s disease from the perspective of ferroptosis. Chem. Biol. Interact., 375.10.1016/j.cbi.2023.110387 ↗
9. Kontoghiorghes, G.J. (2023). The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases. Pharmaceuticals, 16.10.3390/ph16071016 ↗
10. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools10.1111/j.1365-2141.1993.tb03184.x ↗
11. Population pharmacokinetics of deferiprone in healthy subjects10.1111/bcp.12473 ↗
12. Patharapankal, E.J., Ajiboye, A.L., Mattern, C., and Trivedi, V. (2024). Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders. Pharmaceutics, 16.10.3390/pharmaceutics16010066 ↗
13. Gandhi, S., Shastri, D.H., Shah, J., Nair, A.B., and Jacob, S. (2024). Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport. Pharmaceutics, 16.10.3390/pharmaceutics16040481 ↗
14. Jin, Z., Guo, G., Yu, A., Qian, H., and Tong, Z. (2024). Comparative Analysis of Micrometer-Sized Particle Deposition in the Olfactory Regions of Adult and Pediatric Nasal Cavities: A Computational Study. Pharmaceutics, 16.10.3390/pharmaceutics16060722 ↗
15. Mechanisms of pharmaceutical aerosol deposition in the respiratory tract10.1208/s12249-014-0092-0 ↗
16. Particulate formulations based on chitosan for nose-to-brain delivery of drugs10.1016/j.jddst.2015.05.002 ↗
17. Brain uptake of an anti-ischemic agent by nasal administration of microparticles10.1002/jps.21335 ↗
18. Maaz, A., Blagbrough, I.S., and De Bank, P.A. (2021). In Vitro Evaluation of Nasal Aerosol Depositions: An Insight for Direct Nose to Brain Drug Delivery. Pharmaceutics, 13.10.3390/pharmaceutics13071079 ↗
19. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives10.1016/j.addr.2005.07.009 ↗
20. Adnet, T., Groo, A.-C., Picard, C., Davis, A., Corvaisier, S., Since, M., Bounoure, F., Rochais, C., Le Pluart, L., and Dallemagne, P. (2020). Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. Pharmaceutics, 12.10.3390/pharmaceutics12030251 ↗
21. Olfactory Targeting of Microparticles through Inhalation and Bi-directional Airflow: Effect of Particle Size and Nasal Anatomy10.1089/jamp.2019.1549 ↗
22. Action of phenolic derivatives (acetaminophen. salicylate. and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers10.1006/abbi.1994.1485 ↗
23. Peters, T. (1995). All about Albumin: Biochemistry. Genetics. and Medical Applications. 2—The Albumin Molecule: Its Structure and Chemical Properties, Academic Press.10.1016/B978-012552110-9/50004-0 ↗
24. Nickel(II)-Schiff base complex recognizing domain ii of bovine and human serum albumin: Spectroscopic and docking studies10.1016/j.saa.2012.02.060 ↗
25. Evaluating the mucoadhesive properties of drug delivery systems based on hydrated thiolated alginate10.1016/j.jconrel.2009.01.029 ↗
26. Mucoadhesive drug delivery: Mechanism and method of evaluation
27. Assessment of test methods evaluating mucoadhesive polymers and dosage forms: An overview10.1016/j.ejpb.2013.06.023 ↗
28. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method10.1016/S0142-9612(00)00178-2 ↗
29. Double emulsions (W/O/W emulsions): Encapsulation of Plant Biactives
30. Mohan, C.O., Carvajal-Millan, E., Ravishankar, C.N., and Haghi, A.K. (2018). Simple and multiple emulsions emphasizing on industrial applications and stability assessment. Food Process Engineering and Quality Assurance, Apple Academic Press. [1st ed.].10.1201/9781315232966 ↗
31. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery10.3109/10717544.2014.948643 ↗
32. The return of a forgotten polymer—Polycaprolactone in the 21st century10.1016/j.progpolymsci.2010.04.002 ↗
33. A Review on the Recent Research of Polycaprolactone (PCL)10.4028/www.scientific.net/AMR.1134.249 ↗
34. Bhadran, A., Shah, T., Babanyinah, G.K., Polara, H., Taslimy, S., Biewer, M.C., and Stefan, M.C. (2023). Recent Advances in Polycaprolactones for Anticancer Drug Delivery. Pharmaceutics, 15.10.3390/pharmaceutics15071977 ↗
35. Poly-epsilon-caprolactone microspheres and nanospheres: An overview10.1016/j.ijpharm.2004.01.044 ↗
36. Drug release optimization from microparticles of poly (E-caprolactone) and hydroxypropyl methylcellulose polymeric blends: Formulation and characterization10.1016/S1773-2247(14)50126-8 ↗
37. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres10.1016/S0168-3659(03)00367-5 ↗
38. A new deferiprone controlled release system obtained by ultrasound-assisted compression10.3109/10837450.2013.829091 ↗
39. Lukova, P., and Katsarov, P. (2023). Contemporary Aspects of Designing Marine Polysaccharide Microparticles as Drug Carriers for Biomedical Application. Pharmaceutics, 15.10.3390/pharmaceutics15082126 ↗
40. Cherait, A., Banks, W.A., and Vaudry, D. (2023). The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease. Pharmaceutics, 15.10.3390/pharmaceutics15082032 ↗
41. Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches10.1016/j.ejps.2018.10.026 ↗
42. Lai, J., Azad, A.K., Sulaiman, W.M.A.W., Kumarasamy, V., Subramaniyan, V., and Alshehade, S.A. (2024). Alginate-Based Encapsulation Fabrication Technique for Drug Delivery: An Updated Review of Particle Type, Formulation Technique, Pharmaceutical Ingredient, and Targeted Delivery System. Pharmaceutics, 16.10.3390/pharmaceutics16030370 ↗
43. Sundararajan, P., Moser, J., Williams, L., Chiang, T., Riordan, C., Metzger, M., Zhang-Plasket, F., Wang, F., Collins, J., and Williams, J. (2023). Driving Spray Drying towards Better Yield: Tackling a Problem That Sticks Around. Pharmaceutics, 15.10.3390/pharmaceutics15082137 ↗
44. Scale-up of pharmaceutical spray drying using scale-up rules: A review10.1016/j.ijpharm.2019.03.047 ↗
45. Spray dried powders for nasal delivery: Process and formulation considerations10.1016/j.ejpb.2022.05.002 ↗
46. Optimization of Chitosan Microspheres Spray Drying via 32 Full Factorial Design10.1515/folmed-2017-0037 ↗
47. Spray-dried alginate microparticles carrying caffeine-loaded and potentially bioactive nanoparticles10.1016/j.foodres.2014.05.040 ↗
48. Considerations for the Development of Nasal Dosage Forms10.1007/978-1-4614-7978-9_5 ↗
49. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery10.4155/tde-2019-0086 ↗
50. Opportunity and challenges of nasal powders: Drug formulation and delivery10.1016/j.ejps.2017.09.027 ↗
51. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer10.1016/j.ejpb.2004.10.002 ↗
52. Spray-dried alginate microparticles for potential intranasal delivery of ropinirole hydrochloride: Development, characterization and histopathological evaluation10.1080/10837450.2019.1567762 ↗
53. Spray-Dried Nanoparticle-Loaded Pectin Microspheres for Dexamethasone Nasal Delivery10.1080/07373937.2018.1545783 ↗
54. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery10.1016/j.ejps.2009.07.003 ↗
55. Formulation of the In-Situ Forming Mucoadhesive Nasal Gel of Salbutamol Using Pluronic F-127 as Thermo sensative Gel Forming Polymer
56. Development and evaluation of bioadhesive buccal films based on sodium alginate for allergy therapy10.1016/j.heliyon.2022.e10364 ↗
57. Preparation and evaluation of fenoterol hydrobromide suppositories10.5582/ddt.2011.v5.6.311 ↗
58. Design and development of sublingual fast dissolving films for an antiasthmatic drug
59. Development of sustained release matrix tablets of salbutamol sulphate using different polymers
60. Comparative study of desferrioxamine and deferiprone protects against aluminum induced compositional, structural and functional changes in liver tissue of mice (mus musculus) investigated by FT-IR spectroscopy
61. Polycaprolactone Based Nanoparticles Loaded with Indomethacin for Anti-Inflammatory Therapy: From Preparation to Ex Vivo Study10.1007/s11095-017-2166-7 ↗
62. Characterization of sodium alginate based films
63. The effect of cilia and the mucociliary clearance on successful drug delivery10.1248/bpb.b14-00398 ↗
64. Nasal mucociliary clearance as a factor in nasal drug delivery10.1016/S0169-409X(97)00059-8 ↗
65. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note10.1208/pt040339 ↗
66. Bassi da Silva, J., Ferreira, S.B.d.S., Reis, A.V., Cook, M.T., and Bruschi, M.L. (2018). Assessing Mucoadhesion in Polymer Gels: The Effect of Method Type and Instrument Variables. Polymers, 10.10.3390/polym10030254 ↗
67. Techniques for the Assessment of Mucoadhesion in Drug Delivery Systems: An Overview10.1163/156856111X610171 ↗
68. Studies on the nature of interaction of iron(III) with alginates10.1016/j.bbagen.2003.11.001 ↗
69. Human Albumin Impairs Amyloid β-peptide Fibrillation Through its C-terminus: From docking Modeling to Protection Against Neurotoxicity in Alzheimer’s disease10.1016/j.csbj.2019.06.017 ↗
70. Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge10.1186/s11671-018-2729-5 ↗
71. Dai, J., Chen, C., Yin, M., Li, H., Li, W., Zhang, Z., Wang, Q., Du, Z., Xu, X., and Wang, Y. (2023). Interactions between gold nanoparticles with different morphologies and human serum albumin. Front. Chem., 11.10.3389/fchem.2023.1273388 ↗
72. Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles—A fluorescence correlation spectroscopy study10.3762/bjnano.5.212 ↗